NorthWest Biotherapeutics Inc (NWBO)

[jimmy667]

If Linda Powers and management take the optimal strategy to Uplist NWBO to NYSE Amex or to NASDAQ just before or at the same time they announce MNRA approval especially if there is also I partnership or major investment that that revalues the stock of NWBO then the price of the transition shares NWBOD might flash over to geometrically higher price. The volume on the first few days might be in the hundreds of Millions as the  stock is churned over and over by HF Trading Algorithms of the Market Makers. New large investors both instructional and large private might bid the stock up so high that a lot of retail will lose there heads and sell into the churn fray maybe for cheaper than where the price settles. A lot of brokerages do not allow market orders so trying to buy back in after a premature sell might be difficult. Do not for your Grandchildren's or your favorite Charities sake under value NWBO's Market Cap going forward. Do some comparisons to what some cancer companies with promising clinical results but not even approved yet or in commercial stage production were bought for by BP's. A mere $3 billion market cap would make the stock price more than 10x from where it is now. I believe fair analysis will conclude that the value of NWBO should be valued at geometrically higher than a mere 3 billion dollars. I am not sure that the stock can be fairly valued on the OTC. I do believe that management has been working on strategy to Uplist the stock as the company has had an Uplisting expert consultant or staff for several years working on that. I believe it'll take three or four days and hundreds of millions of shares traded after approval to find NWBO's new trading range. During that time I believe that some of the tools that one would use like trailing stops and strategies to buy back in may not work as the stock will be trading so fast and some brokerages may not have the ability to execute market orders.